The two day Symposium served as a convergence point for innovators, industry partners, and investors, offering a unique opportunity to explore partnering opportunities in life science sectors. Through a series of presentations and networking events, innovators had the opportunity to share their groundbreaking work while industry partners and investors shared what they were looking for. The Symposium showcased some of WA's formidable platform capabilities, emphasising the region's prowess in driving cutting-edge advancements in the life science sector. To access the photos from the symosium ..read more

04/04/24 - A cross-town collaboration involving researchers from the Harry Perkins Institute of Medical Research, St John of God Subiaco Hospital, Curtin University, Clinipath, The University of Western Australia (UWA) and Edith Cowan University has found that ovarian tumours alter their local environment by changing the sets of messages they send to cells nearby.   Using an advanced technique known as spatial transcriptomics the team generated cellular maps of ovarian cancer samples from patients in Perth who kindly donated their tumours for research.   Surprisingly, this revealed t ..read more

02/04/24 - MS is a debilitating and progressive condition where a person’s immune system mistakenly attacks the brain and spinal cord. More than 33,000 Australians currently live with the disease, for which there is currently no cure.  Dr Stephanie Trend (from The University of Western Australia’s Medical School, an Honorary Research Associate at the Telethon Kids Institute and an MSWA Research Fellow at the Perron Institute), will lead a team in investigating the way B cells, a type of immune cell, react to perceived threats, and how this may in turn activate MS.  “We know that B ..read more

02/04/24 - Researchers from Western Australia’s Perron Institute have contributed to this investigation of an inflammatory disease which damages the myelin that insulates the nerves of the central nervous system (brain, spinal cord and optic nerves).  Damage to myelin causes disruption in the transmission of nerve signals in the body and a variety of symptoms. The disease studied in this recent research and sometimes misdiagnosed as MS is called myelin oligodendrocyte antibody-associated disease (MOGAD).   In adults it can cause eye pain and loss or blurring of vision (optic n ..read more

Are you or someone you know an entrepreneur eager to showcase your medical technology innovation? The Early-Stage Innovation Forum at AusMedtech 2024 invites you to step into the spotlight. This is your chance to gain invaluable feedback from industry mavens, corporate venture capitalists, and early-stage investors, propelling your journey towards commercial success. Companies that have progressed beyond this early-stage are invited to express their interest in the inaugural AusMedtechInvest 2024 event. Submit your early-stage project by 29 March to present at AusMedtech 2024 for the chan ..read more

29/02/24 - The initial development of a novel drug treatment for children living with rare genetic diseases including Angelman syndrome has been supported by a Channel 7 Telethon Trust grant.   World Rare Disease Day is Thursday 29 February 2024.   The research focuses on three imprinting disorders (congenital conditions) associated with faulty genes on chromosome 15: Angelman syndrome (AS), Prader-Willi syndrome (PWS) and 15q11-q13 duplication syndrome (dup15q).   Affected children can experience developmental delays, impaired balance, seizures, difficulty with feeding, swallow ..read more

29/02/24 - The Future Health Research and Innovation (FHRI) Fund Enabling Scheme aims to increase the scale and excellence of health and medical research and innovation in WA by supporting accessible local infrastructure. The FHRI Fund Enabling Scheme will provide support for capital costs associated with undertaking health and medical research and/or innovation in Western Australia. Up to 50 per cent co-funding will be made available for upgrades to laboratory, research and/or innovation facilities in order to provide greater sector access, or better support national or international partners ..read more

In this episode of the LSWA podcast, host Tracey Wilkinson interviews Fleta Solomon and Michael Winlo, two experts in the field of psychedelic-assisted therapy and medical cannabis. They discuss the potential of these treatments to revolutionise mental health care and provide a more holistic approach to patient care. The conversation begins with a focus on the use of cannabis to achieve high THC effects for certain patients. Fleta and Mike emphasise the importance of therapy in every treatment plan, whether it be through coaching, encouragement, or support in using medication effectively. They ..read more

In this episode of the LSWA podcast, host Tracey Wilkinson sits down with Natalie Barber, the director of Clinical Operations at Chrysalis Advisory, and Professor Peter Richmond from the University of Western Australia.  Natalie and Peter discuss their respective roles in the clinical trial space. Peter, a paediatrician, focuses on improving children's health by conducting research on vaccines and monoclonal antibodies. He shares his involvement in every stage of the clinical trial process, from vaccine design to regulatory advisory boards. Natalie's role is to support clinician researche ..read more

You are invited to attend the 5th Annual Western Australian BioInnovation Symposium to be held in Perth on 22-23 February 2024. The WA BioInnovation Symposium is a premier event in Western Australia that showcases the latest and greatest in life sciences innovations. The symposium serves as a convergence point for innovators, industry partners, and investors, offering a unique opportunity to explore partnering opportunities in life science sectors. The symposium will build on the outstanding program of previous years and for the first year, have a broader life sciences focus, such as agbi ..read more